Close Menu

NEW YORK (GenomeWeb) – Pillar Biosciences announced a strategic partnership and joint venture with China Biotech Services Holdings today that is aimed at the precision diagnostics market in Asia.

Pillar Bio will create a JV with Central Laboratory, a subsidiary of China Biotech Services, to provide precision diagnostic products and services to Hong Kong, Macau, South Korea, and Southeast Asia. Additionally, the JV will distribute Pillar Bio's products, including the SLIMamp and Pivat-based cancer panels, in parts of China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
13
Sponsored by
Beckman Coulter Life Sciences

Mitigation of the SARS-CoV-2 pandemic will continue to require innovative solutions. This webinar will outline how Fry Laboratories rapidly redeployed a next-generation sequencing (NGS) pipeline originally created for the detection and identification of bacterial, eukaryotic, and fungal infections in response to SARS-CoV-2.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.